Market Research Report
Ventricular Assist Devices Market by Product (Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), and Biventricular Assist Device (BIVAD)), Application, and Design - Global Opportunity Analysis and Industry Forecast, 2017-2023
|Published by||Allied Market Research||Product code||622017|
|Published||Content info||190 Pages
Delivery time: 1-2 business days
|Ventricular Assist Devices Market by Product (Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), and Biventricular Assist Device (BIVAD)), Application, and Design - Global Opportunity Analysis and Industry Forecast, 2017-2023|
|Published: March 1, 2018||Content info: 190 Pages||
Ventricular assist device is a mechanical pump used to support the function of left, right, or both ventricles. These devices are used to support cardiac circulation in people who have reached the end-stage heart failure. The global ventricular assist devices market garnered $809 million in 2016, and is anticipated to reach $1,773 million, growing at a CAGR of 11.8%.
Growth in incidences of heart failure across the globe, new technological advancements in ventricular assist devices, awareness among patients about monitoring of the heart, and shortage of heart donors drive the market. Moreover, emerging countries such as developing and under-developed nations provide lucrative opportunities for the market to witness growth. However, the market is restrained by high cost of the procedure and certain risks associated with the VAD implantation procedure.
The global ventricular assist devices market is segmented into product, application, design, and region. Based on product, it is divided into left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), and biventricular assist devices (BIVADs). By application, the market is classified into bridge-to-transplant (BTT) therapy, destination therapy, bridge-to-recovery (BTR) therapy, and bridge-to-candidacy (BTC) therapy. Based on design, the market is bifurcated into transcutaneous and implantable ventricular assist devices. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players profiled in this report are as follows: